Chimeric antigen receptor dendritic cells suppress melanoma growth in preclinical cancer models


Journal article


Julia Minnee, Wallace ZH Wong, Benjamin S Russell, Jose LM Semana, Ruofan Li, Nathaniel R Landau, Takuya Tada
Journal for ImmunoTherapy of Cancer, vol. 13(12), 2025, pp. e013040


Cite

Cite

APA   Click to copy
Minnee, J., Wong, W. Z. H., Russell, B. S., Semana, J. L. M., Li, R., Landau, N. R., & Tada, T. (2025). Chimeric antigen receptor dendritic cells suppress melanoma growth in preclinical cancer models. Journal for ImmunoTherapy of Cancer, 13(12), e013040. https://doi.org/10.1136/jitc-2025-013040


Chicago/Turabian   Click to copy
Minnee, Julia, Wallace ZH Wong, Benjamin S Russell, Jose LM Semana, Ruofan Li, Nathaniel R Landau, and Takuya Tada. “Chimeric Antigen Receptor Dendritic Cells Suppress Melanoma Growth in Preclinical Cancer Models.” Journal for ImmunoTherapy of Cancer 13, no. 12 (2025): e013040.


MLA   Click to copy
Minnee, Julia, et al. “Chimeric Antigen Receptor Dendritic Cells Suppress Melanoma Growth in Preclinical Cancer Models.” Journal for ImmunoTherapy of Cancer, vol. 13, no. 12, 2025, p. e013040, doi:10.1136/jitc-2025-013040.


BibTeX   Click to copy

@article{julia2025a,
  title = {Chimeric antigen receptor dendritic cells suppress melanoma growth in preclinical cancer models},
  year = {2025},
  issue = {12},
  journal = {Journal for ImmunoTherapy of Cancer},
  pages = {e013040},
  volume = {13},
  doi = {10.1136/jitc-2025-013040},
  author = {Minnee, Julia and Wong, Wallace ZH and Russell, Benjamin S and Semana, Jose LM and Li, Ruofan and Landau, Nathaniel R and Tada, Takuya}
}